semaglutide cv outcomes 🔴Cardiovascular with by severity of chronic kidney disease in type 2 diabetes: the FLOW trial⤵️ 🔹Semaglutide significantly reduced the risk of death/MI/stroke regardless of baseline CKD severity in participants Semaglutide cardiovascular outcomes align more

Observational data from the Osteoporotic Fracture in Men (MrOS) study suggested that men with T2DM treated with metformin showed slower loss of muscle mass measured by DXA over time than those not treated with insulin-sensitising agents [102]

Given the intermediary role of oxidative stress in palmitate-induced injury, we hypothesized that GLP-1R signaling may re-shape the oxidative balance by suppressing the generation of ROS and enhancing antioxidant defenses

Dulaglutide (Trulicity) Indications : Primarily for type 2 diabetes, but off-label use for weight loss exists

Yes, headaches are a recognized side effect of GLP-1 medications